RLAY
Relay Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -6.7% ·
flujo de acciones -3.9% ·
nuevas posiciones netas -14.3%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +5 | 111.06M | $2.04B | +12 | −7 |
| Q1 2026 | 92 | +9 | 68.30M | $679.13M | +15 | −7 |
| Q4 2025 | 84 | +2 | 73.82M | $624.52M | +3 | — |
| Q3 2025 | 14 | -1 | 56.07M | $292.70M | — | −2 |
| Q2 2025 | 13 | 0 | 54.62M | $188.99M | +1 | −1 |
| Q1 2025 | 10 | -2 | 33.93M | $88.91M | — | −2 |
| Q4 2024 | 12 | 0 | 26.38M | $108.69M | — | — |
| Q3 2024 | 11 | 0 | 24.01M | $170.03M | +2 | −2 |
| Q2 2024 | 11 | — | 15.37M | $100.25M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 14.77M | +9.9% | $77.12M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 9.40M | +0.2% | $49.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 9.40M | +0.2% | $49.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 9.40M | +0.2% | $49.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 9.40M | +0.2% | $49.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 9.40M | +0.2% | $49.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (pasivo) | 5.07M | -2.6% | $26.44M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasivo) | 3.05M | -5.4% | $15.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (pasivo) | 3.05M | -5.4% | $15.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 1.87M | — | $9.76M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 1.87M | — | $9.76M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 1.76M | — | $9.21M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 1.76M | — | $9.21M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 1.76M | — | $9.21M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 1.76M | — | $9.21M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 1.76M | — | $9.21M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 1.76M | — | $9.21M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 1.30M | +20.1% | $6.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 1.30M | +20.1% | $6.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 1.30M | +20.1% | $6.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 1.30M | +20.1% | $6.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 1.30M | +20.1% | $6.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 1.14M | -60.4% | $5.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | T. Rowe Price ✦ | 1.14M | -60.4% | $5.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 1.10M | +7.1% | $5.72M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | Renaissance Technologies ✦ | 1.02M | -32.2% | $5.34M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 924.76K | — | $4.83M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Millennium Management ✦ | 744.04K | -60.2% | $3.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 162.74K | +2.9% | $849,511 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | Fidelity (FMR) ✦ | 162.74K | +2.9% | $849,511 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Norges Bank | $2.89M | era 0.0% |
| Marshall Wace | $178,874 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 240 tenedores, 183.00M acciones, $1.79B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 17.72K acc. · $349,734
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología